GBIM OTC
GlobeImmune, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -85.7%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$7M
+29.1% ▲
Capital Expenditures
$36K
+87.9% ▲
5Y CAGR: -56.8%
Free Cash Flow
-$7M
+30.7% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$7M
-163.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$14M | -$2M | $9M | -$16M | -$3M |
| Depreciation & Amort. | $952K | $925K | $771K | $295K | $187K |
| Stock-Based Comp. | $330K | $369K | $183K | $49K | $152K |
| Change in Working Capital | $6M | -$10M | -$5M | -$5M | -$5M |
| Other Non-Cash Items | $1M | -$2M | -$2M | $6M | -$159K |
| Operating Cash Flow | -$5M | -$13M | $4M | -$10M | -$7M |
| — Investing Activities — | |||||
| Capital Expenditures | -$133K | -$109K | -$12K | -$294K | -$36K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $254K |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $127K | $254K |
| Investing Cash Flow | -$133K | -$109K | -$12K | -$167K | $218K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $8M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $25K | $0 | -$4M | $0 |
| Financing Cash Flow | $1K | $25K | $2K | $21M | $0 |
| Net Change in Cash | -$5M | -$13M | $4M | $11M | -$7M |
| Cash End of Period | $15M | $2M | $6M | $17M | $10M |
| Free Cash Flow | -$5M | -$13M | $4M | -$10M | -$7M |